Acute Poliomyelitis Clinical Presentation

  • Author: Christine Weiler, MD; Chief Editor: Denise I Campagnolo, MD, MS   more...
 
Updated: Jan 18, 2012
 

History

Most patients (95%) with poliomyelitis virus infections are asymptomatic or have only mild systemic symptoms, such as pharyngitis or gastroenteritis. These cases are referred to as minor illness or abortive poliomyelitis. The mild symptoms are related to viremia and immune response against dissemination of the virus. Only 5% of patients exhibit different severities of nervous system involvement, from nonparalytic poliomyelitis to the most severe form of paralytic poliomyelitis.[4]

  • Nonparalytic poliomyelitis or preparalytic poliomyelitis
    • The prodromal symptoms include generalized, nonthrobbing headache; fever of 38-40 º C; sore throat; anorexia; nausea; vomiting; and muscle aches. These symptoms may or may not subside in 1-2 weeks.
    • Headache and fever, as well as signs and symptoms of nervous system involvement (eg, irritability, restlessness, apprehensiveness, emotional instability, stiffness of the neck and back) and Kernig and Brudzinski signs because of meningitis, then may follow.
    • Children generally exhibit milder systemic symptoms than do adults.
    • Preparalytic symptoms also may develop into paralytic ones.
  • Paralytic poliomyelitis
    • The incubation period from virus exposure to the neurologic phase can last 4-10 days but may extend to 4-5 weeks.
    • Severe muscle pain and spasms, followed by weakness, develop. Muscle weakness tends to become maximal within 48 hours but may develop for longer than a week. No progression of weakness should be noted after the temperature drops to normal for 48 hours. Weakness is asymmetric, with the lower limbs affected more than upper limbs.
    • Muscle tone is flaccid, and the reflexes initially are brisk but then become absent. The transient or occasionally persistent coarse fasciculations also are observed frequently in patients with paralytic poliomyelitis.
    • Patients also complain of paresthesias in the affected limbs without real sensation loss.
    • Paralysis remains for days or weeks before slow recovery occurs over months or years. Which factors favor development of paralytic disease remains unclear, but some evidence exists that physical activity and intramuscular injections during the prodrome may be important exacerbating factors.[4]
  • Paralytic poliomyelitis with bulbar involvement
    • The purely bulbar form of poliomyelitis without limb weakness may occur in children, particularly in those whose tonsils and adenoids have been removed.
    • Bulbar paralysis with spinal involvement is more common in adults, most frequently involving the medulla and leading to dysphagia, dysphonia, respiratory failure, and vasomotor disturbance.
    • Patients may have symptoms and signs, such as hiccough, shallowness and slowing of respiration, cyanosis, restlessness, and anxiety.
    • When paralysis of diaphragmatic and intercostal musculature also occurs, patients need immediate respiratory assistance and intensive care because of life-threatening respiratory failure. Cranial nerve and bulbar involvement can cause obstruction, due to decreased respiratory drive and associated problems with mucus plugging or actual pharyngeal weakness-induced direct airway obstruction. The loss of vasomotor control with circulatory collapse also contributes to high mortality.
    • The encephalitic form of poliomyelitis
      • This form is very rare and manifests as agitation, confusion, stupor, and coma.
      • Autonomic dysfunction is common, and it has a high mortality.
Next

Physical

Vital signs are the key to monitoring patients with poliovirus infection.

  • Muscle weakness can be assessed by muscle strength testing.
    • Usually asymmetric proximal weakness is present with more involvement of lumbar than cervical segments and more spinal cord than brainstem segments.
    • The trunk muscles are affected least.
    • Sensation should be within normal limits objectively.
    • Deep tendon reflexes are diminished or absent.
    • Atrophy of muscle may be detected 3 weeks after onset of paralysis, which becomes maximal at 12-15 weeks and remains permanent.
  • Fifty percent of adult patients with poliomyelitis experience transient acute urinary retention.
  • Stiffness and pain in the neck and back because of meningeal irritation, as well as abnormalities of autonomic function, also can be seen in some patients.
  • Cranial nerve involvement
    • Approximately 10-15% of cases affect the lower brainstem motor nuclei.
    • When the ninth and tenth cranial nerve nuclei are involved, patients develop paralysis of pharyngeal and laryngeal musculature. Unilateral or bilateral facial muscles, as well as the tongue and mastication muscles, may become paralyzed.
    • External oculomotor weakness with pupil sparing may occur in rare cases.
    • Direct infection of the brainstem reticular formation can cause breathing and swallowing disruption, as well as loss of control of the cardiovascular system.
Previous
Next

Causes

The carrier with poliomyelitis virus infection is one major source of virus spread from person to person. The major route is oral-fecal transmission. The greatest dissemination of virus occurs within families with poor sanitation and hygiene or crowded circumstances.

Previous
 
 
Contributor Information and Disclosures
Author

Christine Weiler, MD  Staff Physician, Department of Physical Medicine and Rehabilitation, University of Colorado Health Sciences Center

Christine Weiler, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Medical Association, Association of Academic Physiatrists, and Colorado Medical Society

Disclosure: Nothing to disclose.

Coauthor(s)

Selina Yingqi Xing, MD, MS  Staff Physician, Department of Physical Medicine and Rehabilitation, Temple University

Selina Yingqi Xing, MD, MS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Medical Association, and Physiatric Association of Spine, Sports and Occupational Rehabilitation

Disclosure: Nothing to disclose.

Harry Schwartz, MD  Director of Medical Rehabilitation Program & Spinal Cord Injury Program, Moss Rehabilitation Hospital; Clinical Assistant Professor, Department of Physical Medicine and Rehabilitation, Temple University School of Medicine

Harry Schwartz, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Congress of Rehabilitation Medicine, American Medical Association, American Paraplegia Society, American Spinal Injury Association, and Pennsylvania Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Milton J Klein, DO, MBA  Consulting Physiatrist, Heritage Valley Health System-Sewickley Hospital and Ohio Valley General Hospital

Milton J Klein, DO, MBA is a member of the following medical societies: American Academy of Disability Evaluating Physicians, American Academy of Medical Acupuncture, American Academy of Osteopathy, American Academy of Physical Medicine and Rehabilitation, American Medical Association, American Osteopathic Association, American Osteopathic College of Physical Medicine and Rehabilitation, American Pain Society, and Pennsylvania Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Kat Kolaski, MD  Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine

Kat Kolaski, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine and American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Kelly L Allen, MD  Medical Director, Medevals

Disclosure: Nothing to disclose.

Chief Editor

Denise I Campagnolo, MD, MS  Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consortium of MS Centers

Denise I Campagnolo, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neuromuscular and Electrodiagnostic Medicine, American Paraplegia Society, Association of Academic Physiatrists, and Consortium of Multiple Sclerosis Centers

Disclosure: Teva Neuroscience Honoraria Speaking and teaching; Serono-Pfizer Honoraria Speaking and teaching; Genzyme Corporation Grant/research funds investigator; Biogen Idec Grant/research funds investigator; Genentech, Inc Grant/research funds investigator; Eli Lilly & Company Grant/research funds investigator; Novartis investigator; MSDx LLC Grant/research funds investigator; BioMS Technology Corp Grant/research funds investigator; Avanir Pharmaceuticals Grant/research funds investigator

References
  1. Henderson DA. The eradication of smallpox - An overview of the past, present, and future. Vaccine. Dec 19 2011;[Medline].

  2. Progress toward poliomyelitis eradication--Afghanistan and Pakistan, January 2010-September 2011. MMWR Morb Mortal Wkly Rep. Nov 11 2011;60:1523-7. [Medline].

  3. Global routine vaccination coverage, 2010. MMWR Morb Mortal Wkly Rep. Nov 11 2011;60:1520-2. [Medline].

  4. Kindberg E, Ax C, Fiore L, Svensson L. Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis. J Med Virol. May 2009;81(5):933-6. [Medline].

  5. Racaniello VR. One hundred years of poliovirus pathogenesis. Virology. Jan 5 2006;344(1):9-16. [Medline].

  6. Resurgence of wild poliovirus type 1 transmission and consequences of importation--21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep. Feb 17 2006;55(6):145-50. [Medline]. [Full Text].

  7. Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009. MMWR Morb Mortal Wkly Rep. Apr 17 2009;58(14):357-62. [Medline]. [Full Text].

  8. Progress toward interruption of wild poliovirus transmission--worldwide, 2008. MMWR Morb Mortal Wkly Rep. Apr 3 2009;58(12):308-12. [Medline]. [Full Text].

  9. Tsai HC, Hung TH, Chen CC, et al. Prevalence and risk factors for upper extremity entrapment neuropathies in polio survivors. J Rehabil Med. Jan 2009;41(1):26-31. [Medline].

  10. [Best Evidence] Oncu J, Durmaz B, Karapolat H. Short-term effects of aerobic exercise on functional capacity, fatigue, and quality of life in patients with post-polio syndrome. Clin Rehabil. Feb 2009;23(2):155-63. [Medline].

  11. Adams RD, Victor M, Ropper AH. Viral infection. In: Poliomyelitis. Principles of Neurology. 6th ed. 1997:136-7.

  12. Alcala H. [The differential diagnosis of poliomyelitis and other acute flaccid paralyses]. Bol Med Hosp Infant Mex. Feb 1993;50(2):136-44. [Medline].

  13. Birk TJ. Poliomyelitis and the post-polio syndrome: exercise capacities and adaptation--current research, future directions, and widespread applicability. Med Sci Sports Exerc. Apr 1993;25(4):466-72. [Medline].

  14. Centers for Disease Control and Prevention. Poliovirus infections in four unvaccinated children--Minnesota, August-October 2005. MMWR Morb Mortal Wkly Rep. Oct 21 2005;54(41):1053-5. [Medline].

  15. Frustace SJ. Poliomyelitis: late and unusual sequelae. Am J Phys Med. Dec 1987;66(6):328-37. [Medline].

  16. Howard RS. Poliomyelitis and the postpolio syndrome. BMJ. Jun 4 2005;330(7503):1314-8. [Medline]. [Full Text].

  17. Kidd D, Williams AJ, Howard RS. Poliomyelitis. In: Classic Diseases Revisited. 1996:641-647.

  18. Miller MA, Sutter RW, Strebel PM, Hadler SC. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA. Sep 25 1996;276(12):967-71. [Medline].

  19. Price RW, Plum F. Poliomyelitis. In: Handbook of Clinical Neurology. Vol 32. 1978:2091-2092.

  20. Rowland LP. Viral infections of the nervous system: syndrome of acute anterior poliomyelitis. In: Merritt's Neurology. 10th ed. 2000:764-767.

Previous
Next
 
The typical contractures of postpolio residual paralysis.
Orthotic treatment for deformities around the knee in poliomyelitis.
Surgical correction of a fixed flexion deformity of the knee and hip due to iliotibial band contracture, by Souttar and Yount's release.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.